Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stronger caffeine warnings

This article was originally published in The Tan Sheet

Executive Summary

Connecticut Attorney General Richard Blumenthal says May 1 FDA and Novartis should strengthen warning labels on caffeine product NoDoz following the death of a 19-year-old male. Blumenthal urges stronger warning labels about the severe health consequences of overdosing and caffeine toxicity, saying the current warning labels for NoDoz and other pill forms of caffeine are inadequate. He also advises increasing the minimum age for buying NoDoz from 12 to 18. A study reported in January found many multi-ingredient supplements containing caffeine were most commonly tied to supplement-related adverse events (1"The Tan Sheet" Jan. 29, 2007, p. 3)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS100484

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel